Pioneering Drug Discovery and Development
Proprietary positions in the regulation of cellular chronological lifespan allow Chronos Therapeutics’ research to be successfully advanced into pre-clinical stages of development for age-related disease treatments.
Focussed Drug Development
Chronos Therapeutics’ drug development scheme focuses in two main areas:
- Repositioning FDA approved drugs.
- Screening, discovery and development of novel proprietary drug candidates.
- Diseases of Ageing: Osteoporosis, Cancer and Sarcopenia.
- Neurodegenerative Diseases: Parkinson’s Disease, Alzheimer’s Disease, ALS and Orphan Synucleopathies.